Dr. Gary L. Buchschacher
Claim this profileKaiser Permanente-Anaheim
Studies Colorectal Cancer
Studies Cancer
13 reported clinical trials
34 drugs studied
Area of expertise
1Colorectal Cancer
Stage III
Stage IV
Stage II
2Cancer
Stage IV
Stage III
p16 positive
Affiliated Hospitals
Clinical Trials Gary L. Buchschacher is currently running
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
More about Gary L. Buchschacher
Clinical Trial Related6 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Gary L. Buchschacher has experience with
- Fluorouracil
- Irinotecan Hydrochloride
- Leucovorin
- Leucovorin Calcium
- Oxaliplatin
- Paclitaxel
Breakdown of trials Gary L. Buchschacher has run
Colorectal Cancer
Cancer
Colon Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gary L. Buchschacher specialize in?
Gary L. Buchschacher focuses on Colorectal Cancer and Cancer. In particular, much of their work with Colorectal Cancer has involved Stage III patients, or patients who are Stage IV.
Is Gary L. Buchschacher currently recruiting for clinical trials?
Yes, Gary L. Buchschacher is currently recruiting for 7 clinical trials in Anaheim California. If you're interested in participating, you should apply.
Are there any treatments that Gary L. Buchschacher has studied deeply?
Yes, Gary L. Buchschacher has studied treatments such as Fluorouracil, Irinotecan Hydrochloride, Leucovorin.
What is the best way to schedule an appointment with Gary L. Buchschacher?
Apply for one of the trials that Gary L. Buchschacher is conducting.
What is the office address of Gary L. Buchschacher?
The office of Gary L. Buchschacher is located at: Kaiser Permanente-Anaheim, Anaheim, California 92806 United States. This is the address for their practice at the Kaiser Permanente-Anaheim.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.